Le Lézard
Classified in: Environment, Health
Subjects: NPT, PDT, CSR, ENI

Four Hackensack Meridian Health Hospitals First in Nation to Achieve The Joint Commission's Sustainable Healthcare Certification


OAKBROOK TERRACE, Ill. and EDISON, N.J., March 6, 2024 /PRNewswire/ -- Four hospitals within Hackensack Meridian Health, New Jersey's largest and most integrated health network, are first in the nation to achieve The Joint Commission's Sustainable Healthcare Certification (SHC). These hospitals have met rigorous standards and elements of performance to establish structure, rigor, and accountability to accelerate healthcare's growing sustainability efforts.

The four Hackensack Meridian Health hospitals include:

Since the healthcare industry accounts for nearly 9% of the nation's carbon emissions, commitment to keeping people healthy includes recognizing and reducing healthcare's outsized share of carbon emissions. Responding to and recovering from severe weather events (e.g., wildfires, flooding, hurricanes, and other weather-related emergencies) affect entire communities, healthcare organizations, and their patients, staff, and responders.

The Joint Commission's SHC provides a framework to help healthcare organizations begin, continue, or expand their decarbonization efforts. It builds on the momentum of healthcare organizations like Hackensack Meridian Health to lead the way in sustainability excellence by inspiring and guiding others who desire to prioritize greener practices.

To achieve SHC, all four hospitals set priorities and governance for sustainability initiatives, including creating baselines to measure three sources of greenhouse gas (GHG) emissions and developing an action plan to reduce them. The four hospitals also underwent a virtual certification review to assess their compliance with the SHC program's requirements.

"We are incredibly proud to be the first hospital network in the nation to receive The Joint Commission's Sustainable Healthcare Certification," said Robert C. Garrett, FACHE, CEO of Hackensack Meridian Health. "This prestigious recognition is a testament to our unwavering commitment to environmental stewardship and sustainability. As the healthcare industry continues to evolve, we recognize the importance of operating in a responsible and sustainable manner. This certification demonstrates our leadership in this critical area and our dedication to protecting the health of our patients, communities, and planet for generations to come."

As a network, Hackensack Meridian Health has established itself as a national leader in sustainability. Recent achievements include:

Additionally, as one of the original signatories to the White House and U.S. Department of Health and Human Services Climate Pledge, Hackensack Meridian Health's and The Joint Commission have each pledged to reduce GHG emissions by 50% by 2030 and to achieve net zero by 2050.

Hackensack Meridian Health also has been a leader in healthcare equity. Four of its hospitals were among the first in the nation to achieve The Joint Commission's Healthcare Equity Certification in late 2023.

"The link between equity and environmental sustainability in healthcare is undeniable. Not everyone is equally at risk from the effects of climate change. The individuals least able to compensate for the effects are those already burdened with adverse social determinants of health," says Jonathan B. Perlin, MD, PhD, MSHA, MACP, FACMI, president and chief executive officer, The Joint Commission enterprise. "Achieving The Joint Commission's Healthcare Equity Certification and Sustainable Healthcare Certification demonstrate Hackensack Meridian Health's leadership role and commitment toward responsible and ethical practices."

Free resources to help healthcare organizations on their sustainability and equity journeys are available on The Joint Commission website.

About The Joint Commission

Founded in 1951,?The Joint Commission?seeks to continuously improve healthcare for the public, in collaboration with other stakeholders, by evaluating healthcare organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 22,000 healthcare organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in healthcare. Learn more about The Joint Commission at?www.jointcommission.org.

About Hackensack Meridian Health

Hackensack Meridian Health is a leading not-for-profit healthcare organization that is the largest, most comprehensive and truly integrated healthcare network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care. The network has 18 hospitals and more than 500 patient care locations, which include ambulatory care centers, surgery centers, home health services, ambulance services, lifesaving air medical transportation, rehabilitation centers, urgent care centers, physician practice locations, and a fitness and wellness center. With more than 35,000 team members and 7,000 physicians, Hackensack Meridian Health is a distinguished leader in healthcare philanthropy and committed to the health and well-being of communities throughout New Jersey.

The network's notable distinctions include having the only #1 ranked adult and children's hospitals in New Jersey, as ranked by U.S. News & World Report, 2023-24. Hackensack University Medical Center is nationally-ranked by U.S. News & World Report in six specialties. To learn more, visit www.hackensackmeridianhealth.org.

SOURCE Hackensack Meridian Health


These press releases may also interest you

at 02:43
January-March 2024 Net sales, which for the quarter only included royalties, amounted to SEK 156 (520)Net earnings amounted to KSEK -2,946 (-51,658), where exchange rate effects of KSEK 21 358 (435) had a substantial impact.Earnings per share before...

at 02:27
Market Overview The Global Biometric Technologies Market is expected to grow at a compound annual growth rate (CAGR) of around 12% between 2024 and 2031, from an estimated USD 38 billion in 2023 to approximately USD 120 billion by 2031. Our study...

at 02:05
Locate Bio, a pioneering orthobiologics company, today announces the successful completion of an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and BGF. The proceeds will fund a clinical...

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...



News published on and distributed by: